1. Home
  2. RLYB vs EBON Comparison

RLYB vs EBON Comparison

Compare RLYB & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • EBON
  • Stock Information
  • Founded
  • RLYB 2018
  • EBON 2010
  • Country
  • RLYB United States
  • EBON China
  • Employees
  • RLYB N/A
  • EBON N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • EBON Semiconductors
  • Sector
  • RLYB Health Care
  • EBON Technology
  • Exchange
  • RLYB Nasdaq
  • EBON Nasdaq
  • Market Cap
  • RLYB 22.0M
  • EBON 25.3M
  • IPO Year
  • RLYB 2021
  • EBON 2020
  • Fundamental
  • Price
  • RLYB $0.63
  • EBON $3.81
  • Analyst Decision
  • RLYB Hold
  • EBON
  • Analyst Count
  • RLYB 3
  • EBON 0
  • Target Price
  • RLYB $15.00
  • EBON N/A
  • AVG Volume (30 Days)
  • RLYB 458.7K
  • EBON 11.6K
  • Earning Date
  • RLYB 08-07-2025
  • EBON 08-15-2025
  • Dividend Yield
  • RLYB N/A
  • EBON N/A
  • EPS Growth
  • RLYB N/A
  • EBON N/A
  • EPS
  • RLYB N/A
  • EBON N/A
  • Revenue
  • RLYB $761,000.00
  • EBON $7,337,066.00
  • Revenue This Year
  • RLYB N/A
  • EBON N/A
  • Revenue Next Year
  • RLYB N/A
  • EBON N/A
  • P/E Ratio
  • RLYB N/A
  • EBON N/A
  • Revenue Growth
  • RLYB 154.51
  • EBON 104.28
  • 52 Week Low
  • RLYB $0.22
  • EBON $3.00
  • 52 Week High
  • RLYB $1.25
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 64.03
  • EBON 40.66
  • Support Level
  • RLYB $0.53
  • EBON $3.89
  • Resistance Level
  • RLYB $0.65
  • EBON $4.30
  • Average True Range (ATR)
  • RLYB 0.06
  • EBON 0.22
  • MACD
  • RLYB 0.00
  • EBON -0.04
  • Stochastic Oscillator
  • RLYB 90.44
  • EBON 0.00

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: